Kadota Toshihito | Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
スポンサーリンク
概要
- 同名の論文著者
- Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association の論文著者
関連著者
-
Kadota Toshihito
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
KADOTA TOSHIHITO
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
Kadota Toshihito
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
SAGAMI Fumio
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Saito Mamoru
Drug Safety Research Laboratories Eisai Co. Ltd.
-
MATSUZAWA Toshiaki
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
SAITO Mamoru
Japan Pharmaceutical Manufacturers Association (JPMA) QT PRODACT
-
Kimura Juki
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Ando Kentaro
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
OKAYACHI HIROSHI
Japan Pharmaceutical Manufacturers Association
-
KUBOTA KUNITSUGU
Japan Pharmaceutical Manufacturers Association
-
KADOTA TOSHIHITO
Japan Pharmaceutical Manufacturers Association
-
Saito Akemi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
NAGAYAMA Takashi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
SHIBATA Masami
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
SHIBATA Akiko
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
TANIGUCHI Katsuhiko
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Kido Toshihito
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Nakamura Shouhei
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Shibata Akiko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Shibata Masami
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kubota Kunitsugu
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Okayachi Hiroshi
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Taniguchi Katsuhiko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Nagayama Takashi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
NAGAYAMA Takashi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Ando Kentaro
Japan Agency Of Marine-earth Science And Technology
-
Ichitsubo Tatsuya
Japan Pharmaceutical Manufacturers Association
-
FUKUDA HITOSHI
Japan Pharmaceutical Manufacturers Association
-
URANO YOSUKE
Japan Pharmaceutical Manufacturers Association
-
OGAWA CHISATO
Japan Pharmaceutical Manufacturers Association
-
OKUMURA MAKOTO
Japan Pharmaceutical Manufacturers Association
-
KASAHARA KENICHI
Japan Pharmaceutical Manufacturers Association
-
KUME ETSUKO
Japan Pharmaceutical Manufacturers Association
-
KONDA TOMOYUKI
Japan Pharmaceutical Manufacturers Association
-
SHIMIZU KENJI
Japan Pharmaceutical Manufacturers Association
-
TANAKA YOSHITAKA
Japan Pharmaceutical Manufacturers Association
-
NAKAMURA SHOUHEI
Japan Pharmaceutical Manufacturers Association
-
HIRANO FUMIYA
Japan Pharmaceutical Manufacturers Association
-
HONBO TOSHIYASU
Japan Pharmaceutical Manufacturers Association
-
MATSUZAWA TOSHIAKI
Japan Pharmaceutical Manufacturers Association
-
TOYOSHIMA SHIGEKI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
KIDO Akihiko
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Ando Kentaro
Japan Agency For Marine‐earth Sci. And Technol. Yokosuka Jpn
-
Kido Akihiko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Toyoshima Shigeki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Hashimoto Munehiro
Nonclinical Regulatory Sciences Worldwide Safety Sciences Global Research & Development Nagoya L
-
Saito Mamoru
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
HASHIMOTO Munehiro
Japan Pharmaceutical Manufacturers Association (JPMA) QT PRODACT
-
Kawano Shigeo
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
IWANAGA YUJI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
SAITO MAMORU
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
TORII SHINICHI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
NAKAI SHOJI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
HAMADA SHUICHI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
HASHIMOTO MUNEHIRO
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
MORI Tatsuya
Japan Farriers Association
-
KIDO Toshihito
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Hayashi Naoyuki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Ikeda Takanori
Japan Pharmaceutical Manufactures Association (JPMA), Basic Research A1 group GLP requirement subtea
-
Okutsu Hiroshi
Japan Pharmaceutical Manufactures Association (JPMA), Basic Research A1 group GLP requirement subtea
-
Ochi Seishi
Japan Pharmaceutical Manufactures Association (JPMA), Basic Research A1 group GLP requirement subtea
-
Sato Noriyuki
Japan Pharmaceutical Manufactures Association (JPMA), Basic Research A1 group GLP requirement subtea
-
Nomura Shunji
Japan Pharmaceutical Manufactures Association (JPMA), Basic Research A1 group GLP requirement subtea
-
Muraki Yukiko
Japan Pharmaceutical Manufactures Association (JPMA), Basic Research A1 group GLP requirement subtea
-
Ikeda Takanori
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Ochi Seishi
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Ochi Seishi
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Nakai Shoji
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Iwanaga Yuji
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Muraki Yukiko
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Mori Tomohiro
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Shimada Chiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Torii Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Hamada Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
MAEDA KAZUHA
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
YANO KOJI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
Maeda Kazuha
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Toyoshima Shigeki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Sato Noriyuki
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Mori Tatsuya
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Yano Koji
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
著作論文
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 2) : Point of GLP (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 1) : Point of experimental items (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- P8-49 Questionnaire Survey of GLP Operation for S7A Safety Pharmacology Study in Japanese and Foreign CROs(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-09 No-Observed Adverse Effect Level(NOAEL) : Judging Criteria and Purpose in Safety Assessment of Pharmaceuticals(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-08 Questionnaire Survey on No Observed Adverse Effect Level(2) : Regulatory Comments and Company(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-07 Questionnaire Survey on No Observed Adverse Effect Level(1) : Concept of NOAEL(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-48 Questionnaire Survey about GLP Requirements for Safety Pharmacology(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Questionnaire survey of methodologies on respiration systems in safety pharmacological studies (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)